Home » Topics » BioWorld Science

BioWorld Science
RSS

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Feb. 4, 2022

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

Feb. 4, 2022

Researchers present preclinical model of ALS

Feb. 4, 2022

Meta-analysis reveals candidate variants associated with brain traits

Feb. 4, 2022

Co-stimulation with CD81 promotes CAR T-cell transduction toward naive T cells

Feb. 4, 2022

Deep immunophenotyping study characterizes advanced immune aging in individuals with Down syndrome

Feb. 4, 2022

Anakuria's AT-20494 to be studied for ADPKD and other indications

Feb. 3, 2022

Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases

Feb. 3, 2022

CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1

Feb. 3, 2022

PLA2-IIA modulates immunity through its interaction with microbiota

Feb. 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...